A lifetime economic research of universal HLA-B*58:01 genotyping or febuxostat initiation therapy in Chinese gout patients with mild to moderate chronic kidney disease
Article in Pharmacogenetics and Genomics (December 2022)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Pharmacogenetics and Genomics (December 2022)
Book (May 2022)
Book chapter (April 2022)